Last reviewed · How we verify

NCT06944184

Antibiotic Elution After Two-stage Knee Revision

Completed Last updated 25 April 2025
What this trial tests

trial testing Intraarticular microdialysis in Periprosthetic Knee Infection in 10 participants. Completed in 20 July 2024.

Timeline
31 January 2024
Primary endpoint
24 May 2024
20 July 2024

Quick facts

Lead sponsorUniversity Hospital, Bonn
StatusCompleted
Study typeOBSERVATIONAL
Enrollment10
Start date31 January 2024
Primary completion24 May 2024
Estimated completion20 July 2024
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Bonn

Who can join

18 and older, any sex, with Periprosthetic Knee Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to monitor the eluted antibiotic concentrations of gentamicin and vancomycin by a static knee cement spacer in patients being treated for periprosthetic infections of the knee. The main question aims to answer if eluted antibiotics are in a therapeutic range for treatment at sight of infection. Secondarily, local antibiotic concentrations are compared with systemic blood levels, as are systemically applied antibiotics compared to intra-articular concentrations. Intra-articular samples are collected over a 72 hour postoperative period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Periprosthetic Knee Infection

Currently open trials in the same condition.

Other University Hospital, Bonn trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06944184.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing